Report post

Is AbbVie stock a good buy?

AbbVie stock has received a consensus rating of buy. The average rating score is and is based on 35 buy ratings, 8 hold ratings, and 2 sell ratings. What was the 52-week low for AbbVie stock? The low in the last 52 weeks of AbbVie stock was 130.99. According to the current price, AbbVie is 118.64% away from the 52-week low.

Should you buy AbbVie (abbv) stock in 2023?

In 2023, AbbVie's revenue was $54.32 billion, a decrease of -6.44% compared to the previous year's $58.05 billion. Earnings were $4.86 billion, a decrease of -58.91%. According to 11 analysts, the average rating for ABBV stock is "Buy." The 12-month stock price forecast is $178.6, which is an increase of 8.67% from the latest price.

What does abbv stand for?

Source: Kantar Media View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The World's Leading Crypto Trading Platform

Get my welcome gifts